Advertisement

Topics

GSK drops two Ionis drugs in pipeline revamp

05:25 EDT 11 Aug 2017 | BioPharmaDive

The British pharma, fresh off a review of its rare disease business, decided not to exercise options on inotersen and IONIS-FB-LRx.

Original Article: GSK drops two Ionis drugs in pipeline revamp

NEXT ARTICLE

More From BioPortfolio on "GSK drops two Ionis drugs in pipeline revamp"

Quick Search
Advertisement